TrialStem cell research & therapy2022

Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial.

Mahmoud Izadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.